Evidence-aligned surgical cancer care at hub versus spoke hospitals of multihospital systems
Listen to this summary
The authors aimed to compare the quality of surgical cancer care, specifically the provision of evidence-aligned care (EAC), between hub and spoke hospitals within multihospital systems. Their analysis of SEER Medicare patients revealed that while adherence to EAC was generally high for well-adopted practices, patients at spoke hospitals were less likely to receive evidence-aligned care for poorly adopted practices compared to those treated at centralized hubs. The findings suggest that improving care quality may require either centralizing services at hubs or enhancing the dissemination of best practices to spoke hospitals.
This is one of 33,000+ journals available on OSLR. Try it free for 14 days.
Free 14-day trial. 33,000+ journals. Cancel anytime.

More from Journal of the American College of Surgeons
View all →Sep 23, 2026 · Journal of the American College of Surgeons
Increased Medical Debt in Collections 1 Year After Emergency General Surgery Admission
Sep 22, 2026 · Journal of the American College of Surgeons
Normothermic Machine Perfusion, Patient-Centered Recovery, and Graft Survival After Donation-After-Circulatory-Death Liver Transplantation
Sep 22, 2026 · Journal of the American College of Surgeons
Effect of Surgical Subspecialty on Time to Development of Postoperative Venous Thromboembolism
Sep 22, 2026 · Journal of the American College of Surgeons
Long-Term Patient-Reported Outcomes after Robotic, Laparoscopic, and Open Primary Ventral Hernia Repair
Sep 22, 2026 · Journal of the American College of Surgeons
William Athol McElmoyle and the Forgotten Shield: Rediscovering an Early Principle of Safe Cholecystectomy
Sep 21, 2026 · Journal of the American College of Surgeons
Lost in Interpretation: The Case for Standardized Radiologic Reporting of Liver Lesions in Colorectal Liver Metastases
More in Surgery
View all →Sep 23, 2026 · Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Five-Year Follow-Up of the Phase III ASCOT Trial of Adjuvant S-1 After Resection for Biliary Tract Cancer
Sep 23, 2026 · JAMA
Tenecteplase Before Thrombectomy at 4.5 to 24 Hours for Basilar Artery Occlusion: The ATTENTION LATE Randomized Clinical Trial
Sep 23, 2026 · The New England journal of medicine
Phase 1 Study of Anito-cel, a d-Domain BCMA CAR T Cell for Refractory or Recurrent Myeloma
Sep 23, 2026 · The New England journal of medicine
Effect of Screening with Multicancer Early-Detection Test on Late-Stage Cancer Diagnosis
Sep 23, 2026 · Annals of surgical oncology
Real-World Analysis of Neoadjuvant Immunochemotherapy Followed by Surgery in Esophageal Cancer with Baseline Supraclavicular Lymph Node Involvement
Sep 23, 2026 · The New England journal of medicine
Etuvetidigene Autotemcel for the Treatment of Wiskott-Aldrich Syndrome
"Oslr has become part of my weekly routine on my day off. The clinical relevance of the summaries is outstanding — I'd rate it 9/10. Being able to consume research hands-free is a huge advantage for busy physicians."
Dr. Jennifer Thompson
Portland, OR


